
PIM1 Activation in T-ALL: A Therapeutic Vulnerability
Easy text A+ A++ 🌙 5 min Home Author: Marta Irigoyen is a postdoctoral researcher at CIC bioGUNE T-cell acute lymphoblastic leukemia (T-ALL) and T-cell acute lymphoblastic lymphoma (T-LBL) are aggressive hematological malignancies that arise from abnormal activation of oncogenes […]













